Cheng-Zhong Zhang

Dana-Farber Cancer Inst

$3,261,912

Attributed

$7,240,776

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY2017–25

$5M$3.8M$2.5M$1.3M$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$7,240,776 · 4

By mechanism

R01$4,914,027 · 2

U24$1,730,589 · 1

K22$596,160 · 1

Top collaborators

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Malignant Neoplasms”

Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Martha Hering · Westat, Inc.$57,098,843

Research focus

Malignant NeoplasmsChromosomesTumorMutationCellsBioinformaticsNovel StrategiesGenetic TranscriptionDependenceGenomicsGenesEventGenomePrevalenceResearch PersonnelCancer CellHaplotypesCancer GenomicsBiologicalCancer GenomeGenome SequencingGenomic DataExperimental ModelsCancer Type